Unknown

Dataset Information

Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression.


ABSTRACT:

Background

Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability.

Methods

We superimposed epigenomic profiling from hearts and cardiomyocytes, including promoter-capture chromatin conformation information, to identify enhancers for 2 cardiomyopathy genes, MYH7 and LMNA. Enhancer function was validated in human cardiomyocytes derived from induced pluripotent stem cells. We also conducted a genome-wide search to ascertain genomic variation in enhancers p

SUBMITTER: Gacita AM 

PROVIDER: S-EPMC8009836 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature